FDA Greenlights First Gene Therapy for Older SMA Patients, Raising Hope Nationwide
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Itvisma, a new adeno-associated virus vector-based gene therapy for spinal muscular atrophy, extending treatment eligibility to adults and children 2 …
FDA Greenlights First Gene Therapy for Older SMA Patients, Raising Hope Nationwide Read More